Caplin Point Laboratories Q3 Results

  • BSE: 524742
  • NSE: CAPLIPOINT
  • ISIN: INE475E01026
  • Sector: Biotechnology & Drugs
BSE
1,969.554.60 (0.23%)
Volume7.99 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,97713.25 (0.67%)
Volume65.86 K
Updated: Mon 25 Nov, 2024 | 15:29:51
Today: 1,945.00
2,005.00
52-Wk: 1,179.95
2,175.00

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Caplin Point Laboratories Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 435.50410.06-%372.07-%
    Selling/ General/ Admin Expenses Total 36.6735.08-%34.54-%
    Depreciation/ Amortization 13.9011.76-%11.43-%
    Other Operating Expenses Total 66.4473.48-%64.26-%
    Total Operating Expense 307.12284.42-%274.13-%
    Operating Income 128.38125.64-%97.94-%
    Net Income Before Taxes 145.41146.00-%111.74-%
    Net Income 117.20114.87-%97.48-%
    Diluted Normalized EPS 15.3915.06-%12.75-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts